
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $51.6M | $91.2M | $119.7M | $209.7M | $372.1M | |
Revenue Growth (YoY) | -- | 76.74% | 31.25% | 75.19% | 77.44% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $109.2M | $151.4M | $173.3M | $159.7M | $121.9M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $129.8M | $239.5M | $173M | $200.4M | $203.3M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | $26M | $198.9M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$143.2M | -$367.2M | -$325.2M | -$262.5M | -$27.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.8M | $700K | $1.3M | $500K | $1.2M | |
Net Income to Company | -$141.4M | -$367.9M | -$326.5M | -$263M | -$28.6M | |
Minority Interest in Earnings | -$100K | -$3.5M | -$6.9M | -$10.1M | -$11.9M | |
Net Income to Common Excl Extra Items | -$141.5M | -$371.4M | -$333.4M | -$273.1M | -$40.5M | |
Basic EPS (Cont. Ops) | -$40.75 | -$34.11 | -$14.66 | -$11.58 | -$1.64 | |
Diluted EPS (Cont. Ops) | -$40.75 | -$34.11 | -$14.66 | -$11.58 | -$1.64 | |
Weighted Average Basic Share | $3.5M | $10.9M | $22.7M | $23.6M | $24.7M | |
Weighted Average Diluted Share | $3.5M | $10.9M | $22.7M | $23.6M | $24.7M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -$117.2M | -$367.2M | -$325.2M | -$262.5M | -$27.4M | |
Revenue (Reported) | $51.6M | $91.2M | $119.7M | $209.7M | $372.1M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -$117.2M | -$367.2M | -$325.2M | -$262.5M | -$27.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $17M | $24.5M | $39.8M | $85.1M | $110.3M | |
Revenue Growth (YoY) | -- | 44.12% | 62.45% | 113.82% | 29.61% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $34.3M | $44.2M | $45.2M | $32.7M | $25.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $42.2M | $60.7M | $60M | $37.4M | $33.3M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | $147.1M | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$194.8M | -$66.3M | -$67.8M | -$32.9M | -$45.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $100K | $200K | $300K | $200K | -$200K | |
Net Income to Company | -$194.9M | -$66.5M | -$68.1M | -- | -- | |
Minority Interest in Earnings | -$300K | -$1.1M | -$1.7M | -$2.6M | -$2.3M | |
Net Income to Common Excl Extra Items | -$195.2M | -$67.6M | -$69.8M | -$35.7M | -$47.7M | |
Basic EPS (Cont. Ops) | -$50.75 | -$3.01 | -$3.01 | -$1.47 | -$1.91 | |
Diluted EPS (Cont. Ops) | -$50.75 | -$3.01 | -$3.01 | -$1.47 | -$1.91 | |
Weighted Average Basic Share | $3.8M | $22.5M | $23.2M | $24.2M | $25M | |
Weighted Average Diluted Share | $3.8M | $22.5M | $23.2M | $24.2M | $25M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -$194.8M | -$66.3M | -$67.8M | -$32.9M | -$45.6M | |
Revenue (Reported) | $17M | $24.5M | $39.8M | $85.1M | $110.3M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -$194.8M | -$66.3M | -$67.8M | -$32.9M | -$45.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $98.8M | $135M | $255M | $397.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $159.5M | $176.1M | $147.2M | $112.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | $255.1M | $180.4M | $187M | $205.5M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | $169M | $51M | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$238.6M | -$326.7M | -$227.5M | -$40.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $800K | $1.4M | $400K | $700K | |
Net Income to Company | -- | -$239.5M | -$328.1M | -$228M | -- | |
Minority Interest in Earnings | -$400K | -$4.3M | -$7.5M | -$11M | -$11.6M | |
Net Income to Common Excl Extra Items | -- | -$243.7M | -$335.6M | -$238.9M | -$52.5M | |
Basic EPS (Cont. Ops) | -- | -$29.20 | -$14.65 | -$10.05 | -$2.11 | |
Diluted EPS (Cont. Ops) | -- | -$29.20 | -$14.65 | -$10.05 | -$2.18 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -$238.6M | -$326.7M | -$227.5M | -$40.2M | |
Revenue (Reported) | -- | $98.8M | $135M | $255M | $397.3M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -$238.6M | -$326.7M | -$227.5M | -$40.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $17M | $24.5M | $39.8M | $85.1M | $110.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $34.3M | $44.2M | $45.2M | $32.7M | $25.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $42.2M | $60.7M | $60M | $37.4M | $33.3M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | $147.1M | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$194.8M | -$66.3M | -$67.8M | -$32.9M | -$45.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $100K | $200K | $300K | $200K | -$200K | |
Net Income to Company | -$194.9M | -$66.5M | -$68.1M | -- | -- | |
Minority Interest in Earnings | -$300K | -$1.1M | -$1.7M | -$2.6M | -$2.3M | |
Net Income to Common Excl Extra Items | -$195.2M | -$67.6M | -$69.8M | -$35.7M | -$47.7M | |
Basic EPS (Cont. Ops) | -$50.75 | -$3.01 | -$3.01 | -$1.47 | -$1.91 | |
Diluted EPS (Cont. Ops) | -$50.75 | -$3.01 | -$3.01 | -$1.47 | -$1.91 | |
Weighted Average Basic Share | $3.8M | $22.5M | $23.2M | $24.2M | $25M | |
Weighted Average Diluted Share | $3.8M | $22.5M | $23.2M | $24.2M | $25M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -$194.8M | -$66.3M | -$67.8M | -$32.9M | -$45.6M | |
Revenue (Reported) | $17M | $24.5M | $39.8M | $85.1M | $110.3M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -$194.8M | -$66.3M | -$67.8M | -$32.9M | -$45.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $452.3M | $775.6M | $194.5M | $142.1M | $197.6M | |
Short Term Investments | -- | $9.1M | $445.9M | $348.8M | $373.3M | |
Accounts Receivable, Net | $171.2M | $323.4M | $402.5M | $432.1M | $453.1M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $129.4M | $231.6M | $327.3M | $346.9M | $280.8M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $774.2M | $1.4B | $1.4B | $1.3B | $1.4B | |
Property Plant And Equipment | -- | -- | $33M | $45.5M | $37.7M | |
Long-Term Investments | $56M | $64M | $445.9M | $348.8M | $373.3M | |
Goodwill | $47.8M | $53.5M | -- | -- | -- | |
Other Intangibles | $48.6M | $58.1M | $65.7M | $75.7M | $65.1M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $979.4M | $1.6B | $1.6B | $1.5B | $1.5B | |
Accounts Payable | $96M | $182.6M | $234.8M | $286.4M | $267.9M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $98.5M | $182.6M | $234.8M | $286.4M | $267.9M | |
Long-Term Debt | $273M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.2B | $781M | $975.4M | $1.1B | $1.2B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | $100K | -$700K | -$7M | -$2.9M | -$2.7M | |
Common Equity | -$199.6M | $859.6M | $589.9M | $377.9M | $362.1M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $100K | $2.1M | $3.6M | $6.8M | $3.1M | |
Total Equity | -$199.5M | $861.7M | $593.5M | $384.7M | $365.2M | |
Total Liabilities and Equity | $979.4M | $1.6B | $1.6B | $1.5B | $1.5B | |
Cash and Short Terms | $452.3M | $784.7M | $640.4M | $490.9M | $570.9M | |
Total Debt | $273M | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $336.8M | $188.9M | $223.4M | $140.9M | |
Short Term Investments | -- | $348.9M | $308M | $185.5M | $251.9M | |
Accounts Receivable, Net | -- | $407.4M | $444.8M | $445.2M | $499.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | $262.1M | $344.3M | $288.8M | $255.6M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | $1.4B | $1.3B | $1.2B | $1.2B | |
Property Plant And Equipment | -- | $15.9M | $31.2M | $41M | $36.7M | |
Long-Term Investments | -- | $435.4M | $431.4M | $287.4M | $388.3M | |
Goodwill | -- | $53.5M | -- | -- | -- | |
Other Intangibles | -- | $60.6M | $67M | $75.1M | $63.5M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | $1.7B | $1.6B | $1.5B | $1.5B | |
Accounts Payable | -- | $227M | $278.1M | $288.5M | $261.5M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | $230.2M | $278.1M | $288.5M | $261.5M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $865.8M | $1.1B | $1.1B | $1.2B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -$3.3M | -$5.3M | -$3.4M | -$600K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | $3.2M | $4.7M | $3.6M | $2.9M | |
Total Equity | -- | $808.7M | $543M | $354.8M | $325.7M | |
Total Liabilities and Equity | -- | $1.7B | $1.6B | $1.5B | $1.5B | |
Cash and Short Terms | -- | $685.7M | $496.9M | $408.9M | $392.8M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$141.4M | -$367.9M | -$326.5M | -$263M | -$28.6M | |
Depreciation & Amoritzation | $6.7M | $11M | $15.2M | $19.8M | $23.2M | |
Stock-Based Compensation | $17.2M | $24.3M | $61.9M | $57.5M | $38.2M | |
Change in Accounts Receivable | -$35.8M | -$172.6M | -$74.5M | -$61M | -$31.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$65.4M | -$124.5M | -$161.5M | -$92.4M | $47.5M | |
Capital Expenditures | $9.4M | $17.4M | $19.7M | $46.7M | $12M | |
Cash Acquisitions | -$83.7M | -- | -- | -- | $67.2M | |
Cash From Investing | -$2.3M | -$30M | -$405.9M | $57.6M | $30.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $365M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -$1.8M | -$15.6M | |
Other Financing Activities | -$3.9M | $446.3M | -$10.9M | -$15.6M | -$31.2M | |
Cash From Financing | $518.1M | $480.8M | -$6.8M | -$14.6M | -$40.1M | |
Beginning Cash (CF) | $42M | $492.4M | $818.7M | $244.5M | $195.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $450.4M | $326.3M | -$574.2M | -$49.4M | $37.7M | |
Ending Cash (CF) | $492.4M | $818.7M | $244.5M | $195.1M | $232.8M | |
Levered Free Cash Flow | -$74.8M | -$141.9M | -$181.2M | -$139.1M | $35.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$194.9M | -$66.5M | -$68.1M | -- | -- | |
Depreciation & Amoritzation | $2.5M | $3.9M | $4.3M | -- | -- | |
Stock-Based Compensation | $2.5M | $13.4M | $16.1M | -- | -- | |
Change in Accounts Receivable | -$86.4M | -$66.6M | -$55.1M | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$15.5M | -$58.6M | -$35.7M | $17.7M | -$35.6M | |
Capital Expenditures | $6M | $6.2M | $3.9M | $3.4M | $2.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$9M | -$378.2M | $13.8M | $58.5M | -$11M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.7M | -$1.5M | -$1.9M | -$9M | -$7M | |
Cash From Financing | $200K | -$300K | -$1.9M | -$8M | -$6M | |
Beginning Cash (CF) | $492.4M | $818.7M | $244.5M | $195.1M | $232.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$24.3M | -$437.1M | -$23.8M | $68.2M | -$52.6M | |
Ending Cash (CF) | $468.1M | $381.6M | $220.7M | $263.3M | $180.2M | |
Levered Free Cash Flow | -$21.5M | -$64.8M | -$39.6M | $14.3M | -$38.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$239.5M | -$328.1M | -$228M | -- | |
Depreciation & Amoritzation | -- | $12.4M | $15.6M | $21.1M | -- | |
Stock-Based Compensation | $2.5M | $35.2M | $64.6M | $41.4M | $38.2M | |
Change in Accounts Receivable | -- | -$152.8M | -$63M | -$31.8M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$167.6M | -$138.6M | -$39M | -$5.8M | |
Capital Expenditures | $6M | $17.6M | $17.4M | $46.2M | $11.5M | |
Cash Acquisitions | -- | -- | -- | -- | $67.2M | |
Cash From Investing | -- | -$399.2M | -$13.9M | $102.3M | -$39.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $446.5M | -$11.3M | -$22.7M | -$29.2M | |
Cash From Financing | -- | $480.3M | -$8.4M | -$20.7M | -$38.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$86.5M | -$160.9M | $42.6M | -$83.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -$185.2M | -$156M | -$85.2M | -$17.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$194.9M | -$66.5M | -$68.1M | -- | -- | |
Depreciation & Amoritzation | $2.5M | $3.9M | $4.3M | -- | -- | |
Stock-Based Compensation | $2.5M | $13.4M | $16.1M | -- | -- | |
Change in Accounts Receivable | -$86.4M | -$66.6M | -$55.1M | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$15.5M | -$58.6M | -$35.7M | $17.7M | -$35.6M | |
Capital Expenditures | $6M | $6.2M | $3.9M | $3.4M | $2.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$9M | -$378.2M | $13.8M | $58.5M | -$11M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.7M | -$1.5M | -$1.9M | -$9M | -$7M | |
Cash From Financing | $200K | -$300K | -$1.9M | -$8M | -$6M | |
Beginning Cash (CF) | $492.4M | $818.7M | $244.5M | $195.1M | $232.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$24.3M | -$437.1M | -$23.8M | $68.2M | -$52.6M | |
Ending Cash (CF) | $468.1M | $381.6M | $220.7M | $263.3M | $180.2M | |
Levered Free Cash Flow | -$21.5M | -$64.8M | -$39.6M | $14.3M | -$38.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.